- Home
- RRX vs TECH Comparison
RRX vs TECH Comparison
Compare RRX & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRX
- TECH
- Stock Information
- Founded
- RRX 1955
- TECH 1976
- Country
- RRX United States
- TECH United States
- Employees
- RRX N/A
- TECH N/A
- Industry
- RRX
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RRX
- TECH Health Care
- Exchange
- RRX Nasdaq
- TECH Nasdaq
- Market Cap
- RRX 9.2B
- TECH 7.8B
- IPO Year
- RRX 1987
- TECH 1989
- Fundamental
- Price
- RRX $139.68
- TECH $49.89
- Analyst Decision
- RRX Strong Buy
- TECH Buy
- Analyst Count
- RRX 9
- TECH 11
- Target Price
- RRX $171.25
- TECH $72.00
- AVG Volume (30 Days)
- RRX 528.6K
- TECH 2.5M
- Earning Date
- RRX 07-30-2025
- TECH 08-06-2025
- Dividend Yield
- RRX 1.00%
- TECH 0.64%
- EPS Growth
- RRX N/A
- TECH N/A
- EPS
- RRX 3.50
- TECH 0.83
- Revenue
- RRX $5,904,200,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- RRX N/A
- TECH $7.07
- Revenue Next Year
- RRX $3.98
- TECH $5.88
- P/E Ratio
- RRX $40.02
- TECH $60.23
- Revenue Growth
- RRX N/A
- TECH 4.72
- 52 Week Low
- RRX $90.56
- TECH $46.01
- 52 Week High
- RRX $185.28
- TECH $83.62
- Technical
- Relative Strength Index (RSI)
- RRX 55.79
- TECH 49.63
- Support Level
- RRX $138.32
- TECH $49.05
- Resistance Level
- RRX $142.53
- TECH $51.66
- Average True Range (ATR)
- RRX 3.53
- TECH 1.59
- MACD
- RRX -0.82
- TECH 0.17
- Stochastic Oscillator
- RRX 59.19
- TECH 47.40
About RRX Regal Rexnord Corporation
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The four operating segments include Commercial Systems, Industrial Systems, Climate Solutions, and Motion Control Solutions.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.